European Archives - Page 774 of 1168 - European Medical Journal

Changes in Intraocular Pressure During Haemodialysis and the Role of Ultrafiltration Rate

Ocular problems have been reported to exist in patients with end-stage renal disease (ESRD). Discounting ageing itself, which is a known risk factor…

New Aspects of Fibrillary and Immunotactoid Glomerulonephritis

Glomerular deposits with fibrillary structure are encountered in several renal disorders. In some diseases, such as amyloidosis, fibril deposition…

Changes of Salivary Creatinine and Urea in Animal Models of Kidney Disease

Plasma creatinine and urea are widely used as markers of renal function. Saliva is an alternative diagnostic fluid with many advantages in comparison…

Dengue-Associated Acute Kidney Infection: An Updated and Comprehensive Qualitative Review of Literature

Dengue virus infection (DVI) is a vector-borne febrile illness which has a high prevalence in most tropical countries worldwide. DVI can be classified…

Impact of Chronic Kidney Disease on the Drugs Eliminated Predominantly Through a Non-Renal Route: A Proof of Concept Study with Citalopram

Drug dosing in patients with chronic kidney disease (CKD) can be challenging due to the exclusion of such patients in the clinical trials during the drug…

Interventions for Preventing Infectious Complications in Haemodialysis Patients with Central Venous Catheters

Haemodialysis (HD) is the most widely used dialysis modality worldwide and requires vascular access. Access options include arteriovenous fistula…

A Novel Mechanism of Diclofenac’s Action: Inhibition of Kynurenic Acid Production in Rat Kidney In Vitro

Non-steroidal anti-inflammatory drugs (NSAID) are one of the most popular analgesics due to their efficacy and availability over the counter.1 However…

The European Medical Journal Presents: EMJ Rheumatology 2019

EMJ Rheumatology 6.1 is published today, featuring the European Medical Journal’s independent review of EULAR 2019 alongside our in-house feature on…

EMJ Rheumatology 6.1 2019

EMJ Rheumatology 6.1 explores the highlights from the congress, showcasing a selection of peer-reviewed articles.

Optimising Patient Management in Rheumatoid Arthritis: Can We Live Up to Patient Expectations?

Anti-TNF biologics have revolutionised treatment of RA. More recently, the emergence of high-quality biosimilars has provided a cost-effective means of…